Related Symbols : DDAIF, DDAIY, DMLRY

Company : Daimler AG

At last count, 65 companies have permits to test autonomous vehicles in California. And a handful of companies, including Waymo and Zoox, have the additional permit from the California Public Utilities Commission to transport passengers in their robotaxis through the state’s Autonomous Vehicle Passenger Service pilot. It’s a milestone for German automaker Daimler and Bosch, one of the world’s largest automotive tech and hardware suppliers, but the most noteworthy aspect is how the pilot has been structured. The companies’ approach provides a marker of sorts for exactly where the “race” to develop and deploy commercial autonomous vehicle stands. Much of the media coverage has focused on the launch of the pilot or that it will use self-driving Mercedes-Benz S-Class vehicles, the Sonderklasse (special class) of the automaker’s portfolio.

---

Related Symbols : JOUT

Company : Johnson Outdoors Inc.

---

Related Symbols : NFLX

Company : Netflix Inc.

Further, through the first two months of the quarter, the number of U.S. YouTube trailer views for "major" Netflix originals is up 3% year-over-year compared to Q4 of last year, which signals a more engaging content slate, contends Olson.

---

Related Symbols : BCS, JD

Company : Barclays PLC

Long-Term Story Still Intact Near-term, JD stock should be avoided like the plague after breaking below its 50-day moving average. However, given its sizable revenue, margin, and user growth, coupled with strong consumer spending, the shares are a long-term winner.

---

Related Symbols : AGIO, PJC

Company : Agios Pharmaceuticals Inc.

The disclosure at ASH that seven out of the eight initial mitapivat beta thalassemia patients responded was by far the biggest update during the conference, Van Buren tells investors in a research note. During the first half of next year, Agios could see initial sickle cell data from patients treated with mitapivat, which represents an opportunity that is five-fold larger, adds the analyst.

---

Related Symbols : SRDX, VODG, ZBH

Company : Surmodics Inc.

Needham analyst Michael Matson maintained a Hold rating on SurModics (SRDX – Research Report) today. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings. Currently, the analyst consensus on SurModics is a Moderate Buy with an average price target of $56.00. See today’s analyst top recommended stocks >>SurModics’ market cap is currently $553.9M and has a P/E ratio of 74.17. SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry.

---

Related Symbols : BA

Company : The Boeing Company

Cutting its full-year net profit forecast to $25.9 billion, a 5.1% decline from 2018, the International Air Transport Association said an improvement in 2020 was contingent on a “truce” in global trade disputes. In June it had forecast $28 billion in profit this year. “Trade wars produce no winners,” IATA Director General Alexandre de Juniac told an annual media briefing. IATA slashed its full-year global revenue forecast to $838 billion from the $899 billion predicted in June and said it expected an improvement to $872 billion for 2020. “We’ve downgraded our forecasts for 2019 pretty much across the board,” chief economist Brian Pearce said.

---